ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients

ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients

Inherent issues of subjectivity and inconsistency have long plagued immunohistochemistry (IHC)-based Her2 assessment, leading to the repeated issuance of guidelines by the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) for its standardization for breast cancer pati...

Full description

Bibliographic Details
Main Authors: Guohua Yu, Yan Lyu, Lei Jiang, Yunjun Wang, Ying Yin, Jiandi Zhang, Maozhou Yang, Fangrong Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
HER2
QDB
FFPE
LOD
HER2-low
ELISA
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.920698/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.920698/full

Similar Items